The effect of composition on ion release from Ca-Sr-Na-Zn-Si glass bone grafts.
Controlled delivery of active ions from biomaterials has become critical in bone regeneration. Some silica-based materials, in particular bioactive glasses, have received much attention due to the ability of their dissolution products to promote cell proliferation, cell differentiation and activate gene expression. However, many of these materials offer little therapeutic potential for diseased tissue. Incorporating trace elements, such as zinc and strontium, known to have beneficial and therapeutic effects on bone may provide a more viable bone graft option for those suffering from metabolic bone diseases such as osteoporosis. Rational compositional design may also allow for controlled release of these active ions at desirable dose levels in order to enhance therapeutic efficacy. In this study, six differing compositions of calcium-strontium-sodium-zinc-silicate (Ca-Sr-Na-Zn-Si) glass bone grafts were immersed in pH 7.4 and pH 3 solutions to study the effect of glass composition on zinc and strontium release in a normal and extreme physiological environment. The zinc release levels over 30 days for all zinc-containing glasses in the pH 7.4 solution were 3.0-7.65 ppm. In the more acidic pH 3 environment, the zinc levels were higher (89-750 ppm) than those reported to be beneficial and may produce cytotoxic or negative effects on bone tissue. Strontium levels released from all examined glasses in both pH environments similarly fell within apparent beneficial ranges--7.5-3500 ppm. Glass compositions with identical SrO content but lower ZnO:Na(2)O ratios, showed higher levels of Sr(2+) release. Whereas, zinc release from zinc-containing glasses appeared related to ZnO compositional content. Sustainable strontium and zinc release was seen in the pH 7.4 environment up to day 7. These results indicate that the examined Ca-Sr-Na-Zn-Si glass compositions show good potential as therapeutic bone grafts, and that the graft composition can be tailored to allow therapeutic levels of ions to be released.
Murphy
S
S
Medical Engineering Design and Innovation Centre, Cork Institute of Technology, Cork, Ireland.
Boyd
D
D
Moane
S
S
Bennett
M
M
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry; D001861:Bone Regeneration; D016025:Bone Transplantation / Q000295:instrumentation / Q000379:methods*; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000737:chemistry*; D002454:Cell Differentiation; D049109:Cell Proliferation; D005898:Glass; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007477:Ions; D008422:Materials Testing; D015233:Models, Statistical; D011208:Powders; D012825:Silicon / Q000737:chemistry*; D012964:Sodium / Q000737:chemistry*; D013324:Strontium / Q000737:chemistry*; D013499:Surface Properties; D013696:Temperature; D013997:Time Factors; D014961:X-Ray Diffraction; D015032:Zinc / Q000737:chemistry*
D001672:Biocompatible Materials; D007477:Ions; D011208:Powders; D012964:Sodium; D015032:Zinc; D002118:Calcium; D013324:Strontium; D012825:Silicon